RGEN · Company research
Repligen Corp (RGEN): Valuation Analysis
Available valuation snapshots and ratios; unavailable metrics remain blank.
RESEARCH CONTEXT
Understand the numbers
Available valuation snapshots and ratios; unavailable metrics remain blank. Use period, currency, units and source fields when interpreting values.
1records availableHealthcare
Valuation Analysis data
Database-backed records only
| valuation date | price | market cap | enterprise value | pe | forward pe | peg | price sales | price book | price fcf |
|---|---|---|---|---|---|---|---|---|---|
| Oct 8, 2026 | 174.86 | $9,852,214,680 | 9245431680.00 | 738.49146840566674160881 | — | — | — | — | 181.96558480506497834035 |
Informational research only, not financial advice. Forecasts are uncertain and can be wrong.